Trial Profile
A Phase IV, Multi-Center, Double-Blind, Double-Dummy, Randomized, Parallel-Group Study to Compare the Tolerability of Quetiapine Fumarate Immediate Release (Seroquel IR) With Quetiapine Fumarate Extended Release (Seroquel XR) During Initial Dose Escalation in Patients With Bipolar Depression.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 27 Aug 2009 Actual end date (1 Aug 2009) added as reported by ClinicalTrials.gov.
- 27 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.